Author

Matthew V. Cowley

University College LondonORCID 0000-0002-5258-8024Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:biophysical modeling· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Benny ChainiD· 1 shared Christopher R. S. BanerjiiD· 1 shared Gayathri NageswaraniD· 1 shared Gemma Freeman· 1 shared Jacob A. CoheniD· 1 shared Mark VineyiD· 1 shared Peter S. ZammitiD· 1 shared Simon Hunter-BarnettiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Benny ChainORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The T-cell receptor repertoire of wild mice

Jacob A. Cohen, Simon Hunter-Barnett, Gayathri Nageswaran, Suzanne Byrne, Gemma Freeman, Matthew V. Cowley, Benny Chain, Mark Viney

This study examines the T-cell receptor repertoire in wild mice, finding that repertoire diversity varies with age and sex, while richness remains stable.

Discovery Immunology · Jan 1, 2026Peer-reviewedImmunology

Quantifying anti-DUX4 therapy for facioscapulohumeral muscular dystrophy

Matthew V. Cowley, Peter S. Zammit, Christopher R. S. Banerji

This paper develops a mathematical model to evaluate anti-DUX4 therapies for FSHD, finding that reducing DUX4 diffusion is more effective than reducing apoptosis, and that combining strategies yields better results.

bioRxiv · Aug 14, 2024 · PreprintCell Biology